Growing community of inventors

Dublin, OH, United States of America

Robert Brueggemeier

Average Co-Inventor Count = 2.96

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 11

Robert BrueggemeierYoung-Woo Kim (4 patents)Robert BrueggemeierJohn C Hackett (3 patents)Robert BrueggemeierPui-Kai Li (2 patents)Robert BrueggemeierChenglong Li (1 patent)Robert BrueggemeierHarold E Fisk (1 patent)Robert BrueggemeierYasuro Sugimoto (1 patent)Robert BrueggemeierEdgar S Diaz-Cruz (1 patent)Robert BrueggemeierSerena Landini (1 patent)Robert BrueggemeierJ Thomas Pento (1 patent)Robert BrueggemeierBin Su (1 patent)Robert BrueggemeierRobert Brueggemeier (7 patents)Young-Woo KimYoung-Woo Kim (7 patents)John C HackettJohn C Hackett (3 patents)Pui-Kai LiPui-Kai Li (20 patents)Chenglong LiChenglong Li (9 patents)Harold E FiskHarold E Fisk (3 patents)Yasuro SugimotoYasuro Sugimoto (1 patent)Edgar S Diaz-CruzEdgar S Diaz-Cruz (1 patent)Serena LandiniSerena Landini (1 patent)J Thomas PentoJ Thomas Pento (1 patent)Bin SuBin Su (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Ohio State University (6 from 827 patents)

2. Other (1 from 832,812 patents)

3. The University of Oklahoma (1 from 560 patents)


7 patents:

1. 10611765 - Pyrrolopyrimidine derivatives as Mps1/TTK kinase inhibitors

2. 8476313 - Heteroaryl-containing isoflavones as aromatase inhibitors

3. 7960548 - Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastatis

4. 7829557 - 2-heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer

5. 7741520 - Sulfonanilide analogs as selective aromatase modulators (SAMs)

6. 7572919 - Heteroaryl-containing isoflavones as aromatase inhibitors

7. 7105542 - 2-Heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…